A detailed history of Perkins Capital Management Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Perkins Capital Management Inc holds 283,399 shares of AXGN stock, worth $4.67 Million. This represents 3.91% of its overall portfolio holdings.

Number of Shares
283,399
Previous 289,349 2.06%
Holding current value
$4.67 Million
Previous $2.09 Million 89.73%
% of portfolio
3.91%
Previous 2.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$7.52 - $14.69 $44,744 - $87,405
-5,950 Reduced 2.06%
283,399 $3.97 Million
Q2 2024

Aug 09, 2024

SELL
$5.67 - $8.06 $48,762 - $69,316
-8,600 Reduced 2.89%
289,349 $2.09 Million
Q1 2024

May 09, 2024

SELL
$6.63 - $10.69 $11,045 - $17,809
-1,666 Reduced 0.56%
297,949 $2.4 Million
Q4 2023

Jan 22, 2024

SELL
$3.61 - $7.76 $6,227 - $13,386
-1,725 Reduced 0.57%
299,615 $2.05 Million
Q3 2023

Nov 02, 2023

BUY
$4.68 - $9.26 $11,466 - $22,687
2,450 Added 0.82%
301,340 $1.51 Million
Q2 2023

Jul 21, 2023

SELL
$8.5 - $10.38 $90,100 - $110,028
-10,600 Reduced 3.42%
298,890 $2.73 Million
Q1 2023

May 09, 2023

BUY
$7.53 - $10.95 $18,448 - $26,827
2,450 Added 0.8%
309,490 $2.93 Million
Q4 2022

Jan 26, 2023

BUY
$9.44 - $13.09 $3,776 - $5,236
400 Added 0.13%
307,040 $3.06 Million
Q3 2022

Oct 24, 2022

BUY
$8.14 - $12.25 $5,698 - $8,575
700 Added 0.23%
306,640 $3.66 Million
Q2 2022

Jul 29, 2022

BUY
$6.99 - $10.0 $124,072 - $177,500
17,750 Added 6.16%
305,940 $2.51 Million
Q1 2022

Apr 20, 2022

BUY
$7.26 - $10.7 $79,860 - $117,699
11,000 Added 3.97%
288,190 $2.29 Million
Q4 2021

Feb 10, 2022

BUY
$8.8 - $16.0 $34,760 - $63,200
3,950 Added 1.45%
277,190 $2.6 Million
Q3 2021

Oct 25, 2021

BUY
$15.23 - $21.72 $6,092 - $8,688
400 Added 0.15%
273,240 $4.32 Million
Q2 2021

Jul 28, 2021

SELL
$17.8 - $23.5 $82,770 - $109,275
-4,650 Reduced 1.68%
272,840 $5.9 Million
Q4 2020

Feb 09, 2021

SELL
$11.5 - $17.96 $100,050 - $156,252
-8,700 Reduced 3.04%
277,490 $4.97 Million
Q3 2020

Oct 28, 2020

SELL
$10.62 - $13.12 $127,970 - $158,096
-12,050 Reduced 4.04%
286,190 $3.33 Million
Q1 2020

Apr 29, 2020

BUY
$8.38 - $17.34 $12,151 - $25,143
1,450 Added 0.49%
298,240 $3.1 Million
Q4 2019

Feb 03, 2020

SELL
$11.18 - $18.6 $256,972 - $427,521
-22,985 Reduced 7.19%
296,790 $5.31 Million
Q3 2019

Oct 23, 2019

SELL
$12.09 - $20.46 $241,800 - $409,200
-20,000 Reduced 5.89%
319,775 $3.99 Million
Q2 2019

Aug 09, 2019

SELL
$18.5 - $25.47 $172,975 - $238,144
-9,350 Reduced 2.68%
339,775 $6.73 Million
Q1 2019

Apr 22, 2019

SELL
$14.62 - $22.13 $103,071 - $156,016
-7,050 Reduced 1.98%
349,125 $7.35 Million
Q4 2018

Feb 11, 2019

SELL
$17.09 - $38.25 $48,279 - $108,056
-2,825 Reduced 0.79%
356,175 $7.28 Million
Q3 2018

Oct 22, 2018

SELL
$34.05 - $55.9 $227,283 - $373,132
-6,675 Reduced 1.83%
359,000 $13.2 Million
Q2 2018

Aug 02, 2018

SELL
$36.15 - $52.5 $2.26 Million - $3.29 Million
-62,575 Reduced 14.61%
365,675 $18.4 Million
Q1 2018

Apr 23, 2018

SELL
$24.4 - $40.25 $1.61 Million - $2.65 Million
-65,900 Reduced 13.34%
428,250 $15.6 Million
Q4 2017

Jan 26, 2018

SELL
$18.5 - $28.6 $840,788 - $1.3 Million
-45,448 Reduced 8.42%
494,150 $14 Million
Q3 2017

Oct 31, 2017

BUY
$14.65 - $19.35 $7.91 Million - $10.4 Million
539,598
539,598 $10.4 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $697M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.